Lineage Cell Therapeutics, Inc. - Common Stock (LCTX)

Historical Holders from Q2 2019 to Q1 2025

Symbol
LCTX on NYSE
CUSIP
53566P109
Type / Class
Equity / Common Stock
Shares outstanding
219M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
107M
Holdings value
$53.8M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
117
Number of buys
55
Number of sells
-27
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lineage Cell Therapeutics, Inc. - Common Stock (LCTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BROADWOOD PARTNERS, L.P. 24.5% $26.1M 57.8M NEAL C. BRADSHER Jan 27, 2025
BlackRock, Inc. 4.6% $4.56M 10.1M BlackRock, Inc. Dec 31, 2024

Institutional Holders of Lineage Cell Therapeutics, Inc. - Common Stock (LCTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 499K $221K +$58.3K $0.45 13
2024 Q4 107M $53.8M +$3.91M $0.50 117
2024 Q3 94.6M $85.6M -$260K $0.91 113
2024 Q2 94.4M $94.2M +$447K $1.00 111
2024 Q1 93.4M $138M +$26.6M $1.48 113
2023 Q4 75.7M $82.5M -$20.4K $1.09 114
2023 Q3 75.5M $89.1M -$399K $1.18 102
2023 Q2 75.6M $107M +$8.58M $1.41 105
2023 Q1 69.8M $105M +$7.06M $1.50 114
2022 Q4 65.1M $76.1M +$642K $1.17 99
2022 Q3 64.5M $72.9M -$314K $1.13 86
2022 Q2 64.6M $102M -$10.3M $1.58 80
2022 Q1 72.8M $112M -$3.68M $1.54 97
2021 Q4 72.5M $178M -$3.16M $2.45 108
2021 Q3 73.3M $185M +$5.64M $2.52 103
2021 Q2 73.1M $208M +$35.6M $2.85 100
2021 Q1 60.3M $142M +$12.4M $2.35 89
2020 Q4 54.8M $96.4M +$3.09M $1.76 73
2020 Q3 53.6M $50.2M -$1.83M $0.94 63
2020 Q2 55.5M $48.3M -$6.85M $0.87 76
2020 Q1 63.8M $52.8M +$476K $0.83 78
2019 Q4 63.2M $56.2M -$1.2M $0.89 80
2019 Q3 64.4M $63.1M +$63M $0.98 78
2019 Q2 18K $20K +$20K $1.11 1